Jennifer Michaelson
Directeur Technique/Scientifique/R&D chez CULLINAN THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Jennifer Michaelson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2023 | - |
| Corporate Officer/Principal | 01/01/2018 | 01/06/2023 |
Historique de carrière de Jennifer Michaelson
Anciens postes connus de Jennifer Michaelson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/07/2017 | 01/12/2017 |
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2012 | 01/07/2017 |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2018 | - |
Formation de Jennifer Michaelson
| Princeton University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Jennifer Michaelson
- Expérience
